TWD 13.5
(-0.74%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 86.89 Million TWD | -19.84% |
2022 | 108.39 Million TWD | -6.39% |
2021 | 115.78 Million TWD | -8.9% |
2020 | 127.1 Million TWD | -18.66% |
2019 | 156.25 Million TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 70.51 Million TWD | -18.58% |
2024 Q2 | 67.72 Million TWD | 0.0% |
2023 FY | 86.89 Million TWD | -19.84% |
2023 Q2 | 101.97 Million TWD | 0.0% |
2023 Q1 | 101.97 Million TWD | -5.92% |
2023 Q3 | 86.89 Million TWD | -14.79% |
2023 Q4 | 86.89 Million TWD | 0.0% |
2022 Q3 | 108.39 Million TWD | 0.0% |
2022 Q4 | 108.39 Million TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 60.65 Million TWD | -43.26% |
Level Biotechnology Inc. | 9.88 Million TWD | -779.009% |
Sagittarius Life Science Corp | 6.25 Million TWD | -1289.351% |
NeoCore Technology Co., Ltd. | 33.65 Million TWD | -158.202% |
TaiMed Biologics Inc. | 521.7 Million TWD | 83.345% |
GlycoNex Incorporation | - TWD | -Infinity% |
VBI | - TWD | -Infinity% |
GeneReach Biotechnology Corp. | 97.74 Million TWD | 11.103% |
Visgeneer Inc. | 114.17 Million TWD | 23.896% |
Mycenax Biotech Inc. | 569.78 Million TWD | 84.75% |
Sunmax Biotechnology Co., Ltd. | 144.77 Million TWD | 39.983% |
G&E Herbal Biotechnology Co., Ltd. | 1.29 Million TWD | -6614.838% |
Medigen Vaccine Biologics Corporation | 254.35 Million TWD | 65.839% |
TaiwanJ Pharmaceuticals Co., Ltd. | 472 Thousand TWD | -18308.898% |
Enimmune corporation | 1.75 Million TWD | -4839.738% |
TaiRx, Inc. | 8.96 Million TWD | -868.781% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 436.54 Million TWD | 80.096% |
BioLASCO Taiwan Co., Ltd. | 51.43 Million TWD | -68.938% |
Sunny Pharmtech Inc. | 376.29 Million TWD | 76.909% |
Lin BioScience, Inc. | 29.02 Million TWD | -199.352% |
BioGend Therapeutics Co., Ltd. | 9.44 Million TWD | -820.347% |
Feng Chi Biotech Corp. | 8.14 Million TWD | -966.266% |
Bio Preventive Medicine Corp. | 106.2 Million TWD | 18.183% |
Lukas Biomedical Inc. | 69.9 Million TWD | -24.297% |
RBC Bioscience Corporation | 412.59 Million TWD | 78.941% |
BiOptic Inc. | 85.79 Million TWD | -1.28% |
BRIM Biotechnology, Inc. | 108 Thousand TWD | -80353.704% |
Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
Great Novel Therapeutics Biotech & Medicals | 10.88 Million TWD | -698.548% |
Syngen Biotech Co.,Ltd. | 386.07 Million TWD | 77.494% |
Anti-Microbial Savior BioteQ Co., Ltd | - TWD | -Infinity% |
SynCore Biotechnology Co.,Ltd | - TWD | -Infinity% |
Genomics BioSci & Tech. Co.,Ltd. | 222.24 Million TWD | 60.903% |
Neith Corporation | 714 Thousand TWD | -12069.468% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 25.83 Million TWD | -236.301% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 366 Million TWD | 76.26% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 22.02 Million TWD | -294.524% |
Greenyn Biotechnology Co., Ltd | 55.91 Million TWD | -55.391% |
Lumosa Therapeutics Co., Ltd. | 8.11 Million TWD | -970.469% |
AP Biosciences Inc | 70.42 Million TWD | -23.376% |
Medigen Biotechnology Corp. | 449.09 Million TWD | 80.652% |
3D Global Biotech Inc. | 4.08 Million TWD | -2028.613% |
Pharmosa Biopharm Inc. | 118.41 Million TWD | 26.622% |
Intech Biopharm Corporation | 970.4 Million TWD | 91.046% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 78.166% |
Eusol Biotech Co.,Ltd. | 1.6 Million TWD | -5310.336% |
TWi Biotechnology, Inc. | 5.6 Million TWD | -1450.776% |
Ever Supreme Bio Technology Co., Ltd | 503 Thousand TWD | -17174.354% |
TCI GENE Inc. | - TWD | -Infinity% |
MegaPro Biomedical Co., Ltd | 5.62 Million TWD | -1443.888% |
Senhwa Biosciences, Inc. | 3.28 Million TWD | -2543.444% |
Taiwan Bio Therapeutics Co., Ltd | 250.51 Million TWD | 65.315% |
NatureWise Biotech & Medicals Corporation | 3.26 Million TWD | -2561.256% |
PharmaEngine, Inc. | 7.14 Million TWD | -1116.436% |
Savior Lifetec Corporation | 257.03 Million TWD | 66.196% |
TaiGen Biopharmaceuticals Holdings Limited | 58.71 Million TWD | -47.999% |
OBI Pharma, Inc. | 439.88 Million TWD | 80.247% |
Meribank Biotech Co., Ltd | 14.81 Million TWD | -486.659% |
Acepodia, Inc. | 233.45 Million TWD | 62.78% |
Caliway Biopharmaceuticals Co., Ltd. | 11.87 Million TWD | -631.767% |